1 enrolling by invitation. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Enrolling by invitation 1 |
| Phase 2 | 1 | Enrolling by invitation 1 |
Follow Hypogammaglobulinemia: new trials by email Literature Review of Hypogammaglobulinemia trials Research Report on Hypogammaglobulinemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Base-Edited Hematopoietic Stem/Progenitor Cell Gene Therapy for Treatment of CXCR4-WHIM Busulfan, Palifermin, Plerixafor - WHIM, Warts | Phase 1 / Phase 2 | Enrolling by invitation | National Institute of Allergy and Infectious Diseases (NIAID) | 10 | 2026-10-21 | 2026-10-27 |
Agammaglobulinemia (1) · Immunologic Deficiency Syndromes (1) · Warts (1)
Blood Protein Disorders (1) · DNA Virus Infections (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Infections (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Papillomavirus Infections (1) · Skin Diseases (1) · Skin Diseases, Infectious (1) · Skin Diseases, Viral (1) · Skin and Connective Tissue Diseases (1) · Tumor Virus Infections (1) · Virus Diseases (1)
Busulfan (1) · Fibroblast Growth Factor 7 (1) · Filgrastim (1) · plerixafor (1)
National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (1)